Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

26. April 2024 INDIZES USA

BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated therapeu …

Tags: dow jones nasdaq s&p 500

You may also like...